Cambridge Investment Research Advisors, Inc. Sarepta Therapeutics, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 6,387 shares of SRPT stock, worth $352,754. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,387
Previous 6,029
5.94%
Holding current value
$352,754
Previous $733,000
44.34%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding SRPT
# of Institutions
530Shares Held
86MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$570 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$502 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$480 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$239 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$225 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $4.84B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...